Healthy Clinical Trial
Official title:
Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression
The purpose of this study is to determine differences between the immune responses in healthy and depressed people. Participants will receive the influenza vaccine and their responses will be monitored. This study will recruit 15 healthy and 60 depressed participants.
The purpose of this study is to determine differences between the immune responses in healthy
and depressed people. Specifically subjects are provided a mild immune stimulus, an influenza
vaccine, and their responses are monitored. The goals are to determine whether patients with
depression experience a temporary worsening of mood in response to the stimulus and whether
this is associated with measurable differences in the cytokine response to the vaccine.
Additionally, patients with depression may be less likely to mount a successful antibody
response to vaccination as healthy people based on circumstantial evidence, and this study
will assess whether this the case.
This study aims to recruit a sample of 15 healthy and 60 depressed participants. The 15
healthy participants will be age and gender matched to the first 15 depressed participants
recruited. Three more sets of age and gender matched depressed subjects will be recruited.
This will result in 15 sets of "quintuplets" (4 depressed and one healthy), that are matched
by age and gender. The study consists of four visits. The first visit is the baseline
assessment where participants will receive the influenza vaccine. Participants will then
return 1, 3 and 28 days after receiving the vaccine to assess their responses.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT00001844 -
Study of New Magnetic Resonance Methods
|
||
| Completed |
NCT03160261 -
Effect of Exenatide on Cortisol Secretion
|
Phase 4 | |
| Active, not recruiting |
NCT03662100 -
A Study of Two Formulations of LY3074828 in Healthy Participants
|
Phase 1 | |
| Recruiting |
NCT02875301 -
Investigating Gains in Neurocognition in an Intervention Trial of Exercise
|
Phase 3 | |
| Recruiting |
NCT03670082 -
Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State
|
Phase 1 | |
| Recruiting |
NCT03656952 -
A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03203824 -
The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals
|
N/A | |
| Completed |
NCT03056846 -
Probiotics on Stress-associated Gastrointestinal Function in University Students
|
N/A | |
| Recruiting |
NCT03114839 -
Effect of Lactobacillus Casei Shirota on the Small Intestinal Microbiota (ROBIN)
|
N/A | |
| Completed |
NCT03224702 -
First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03259464 -
This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated
|
Phase 1 | |
| Completed |
NCT03309566 -
Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir
|
Phase 4 | |
| Completed |
NCT00527579 -
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
|
Phase 1 | |
| Completed |
NCT00526916 -
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28
|
Phase 1 | |
| Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
| Completed |
NCT03373162 -
Functional Effects of Botox on the Brain Using MRS and fMRI
|
Phase 4 | |
| Active, not recruiting |
NCT02509494 -
Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2
|
Phase 3 | |
| Terminated |
NCT02555085 -
Single Ascending Doses of BIIB063 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03125018 -
Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)
|
N/A |
